๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Randomized phase II trial of sulindac for lung cancer chemoprevention

โœ Scribed by Limburg, Paul J.; Mandrekar, Sumithra J.; Aubry, Marie Christine; Ziegler, Katie L. Allen; Zhang, Jun; Yi, Joanne E.; Henry, Michael; Tazelaar, Henry D.; Lam, Stephen; McWilliams, Annette; Midthun, David E.; Edell, Eric S.; Rickman, Otis B.; Mazzone, Peter; Tockman, Melvyn; Beamis, John F.; Lamb, Carla; Simoff, Michael; Loprinzi, Charles; Szabo, Eva; Jett, James


Book ID
122804270
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
562 KB
Volume
79
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Strategies for phase II cancer chemoprev
โœ Dr. Gary J. Kelloff; Charles W. Boone; James A. Crowell; Susan G. Nayfield; Erne ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 782 KB

Well-designed and conducted Phase 11 clinical trials are very important to cancer chemoprevention drug development. Three critical aspects govern the design and conduct of these trials-wellcharacterized agents, suitable cohorts, and reliable biomarkers for measuring efficacy that can serve as surrog